Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6af0d5c15ba7cd14ac81d0078419a4f3 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2545-114 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B40-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B40-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B25-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B20-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2561-113 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B40-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B5-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B40-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B40-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B25-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B40-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B20-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B5-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B40-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 |
filingDate |
2018-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15df75346cd0066e4b0d22c0850f2624 |
publicationDate |
2019-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2019241972-A1 |
titleOfInvention |
Cluster classification and prognosis prediction system based on biological characteristics of gastric cancer |
abstract |
The present invention relates to a group classification and prognosis prediction system based on the biological characteristics of gastric cancer, and an algorithm capable of predicting the prognosis of advanced gastric cancer in terms of overall survival by using a quantified value of an mRNA expression level of a target gene group has been developed and this may be used as auxiliary information for determining a treatment method of a gastric cancer patient. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019304578-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114720687-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114999569-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110942808-A |
priorityDate |
2017-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |